Cargando…
Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
Endometrial cancer is the most common gynecologic cancer and is predominantly endocrine-related. The role of unopposed estrogen in the development of endometrial cancer has been investigated in numerous studies. Different reproductive factors such as younger age at menarche, late age at menopause, i...
Autores principales: | Ignatov, Atanas, Ortmann, Olaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408229/ https://www.ncbi.nlm.nih.gov/pubmed/32630728 http://dx.doi.org/10.3390/cancers12071766 |
Ejemplares similares
-
An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021) -
Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome
por: Dhaliwal, Lakhbir Kaur, et al.
Publicado: (2011) -
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome
por: Yang, Young-Mo, et al.
Publicado: (2015) -
The Complex Roles of Adipokines in Polycystic Ovary Syndrome and Endometriosis
por: Schüler-Toprak, Susanne, et al.
Publicado: (2022) -
The management of infertility associated with polycystic ovary syndrome
por: Homburg, Roy
Publicado: (2003)